Martin A Osterhoff
Overview
Explore the profile of Martin A Osterhoff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
416
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Gogebakan O, Osterhoff M, Albrecht T
Rofo
. 2018 Sep;
190(11):1044-1052.
PMID: 30189433
Background: Mesenteric panniculitis (MP) is histologically characterized by chronic nonspecific inflammation of the adipose tissue of the intestinal mesentery with unclear etiology. MP occurs predominantly in men, mostly in mid...
12.
Schuler R, Seebeck N, Osterhoff M, Witte V, Floel A, Busjahn A, et al.
Mol Metab
. 2018 Mar;
11:129-136.
PMID: 29506909
Objective: Reduction of brain glucose transporter GLUT1 results in severe neurological dysfunction. VEGF is required to restore and maintain brain glucose uptake across the blood brain barrier via GLUT1, which...
13.
Honsek C, Kabisch S, Kemper M, Gerbracht C, Arafat A, Birkenfeld A, et al.
Diabetologia
. 2018 Mar;
61(6):1295-1305.
PMID: 29492637
Aims/hypothesis: Insoluble cereal fibres have been shown in large prospective cohort studies to be highly effective in preventing type 2 diabetes, but there is a lack of interventional data. Our...
14.
Schuler R, Osterhoff M, Frahnow T, Mohlig M, Spranger J, Stefanovski D, et al.
Sci Rep
. 2017 Aug;
7(1):9234.
PMID: 28835639
The frequent ACE insertion/deletion polymorphism (I/D) is, albeit inconsistently, associated with impaired glucose tolerance and insulin resistance. We recently observed an enhanced upregulation of ACE by elevated fat intake in...
15.
Frahnow T, Osterhoff M, Hornemann S, Kruse M, Surma M, Klose C, et al.
Sci Rep
. 2017 Jun;
7(1):3750.
PMID: 28623287
Lipidomics have a great potential as clinical tool for monitoring metabolic changes in health and disease. Nevertheless hardly anything is known about the heritability of lipids. Therefore, it is necessary...
16.
Schuler R, Osterhoff M, Frahnow T, Seltmann A, Busjahn A, Kabisch S, et al.
J Am Heart Assoc
. 2017 Jan;
6(1).
PMID: 28096099
Background: Angiotensin-converting enzyme (ACE) plays a major role in blood pressure regulation and cardiovascular homeostasis. Contrary to the assumption that ACE levels are stable, circulating ACE has been shown to...
17.
Kruse M, Keyhani-Nejad F, Isken F, Nitz B, Kretschmer A, Reischl E, et al.
Diabetes
. 2015 Dec;
65(3):574-84.
PMID: 26631738
Maternal obesity is a worldwide problem associated with increased risk of metabolic diseases in the offspring. Genetic deletion of the gastric inhibitory polypeptide (GIP) receptor (GIPR) prevents high-fat diet (HFD)-induced...
18.
Gogebakan O, Osterhoff M, Schuler R, Pivovarova O, Kruse M, Seltmann A, et al.
Diabetologia
. 2015 May;
58(8):1759-68.
PMID: 25994074
Aims/hypothesis: Obesity is associated with elevated monocyte chemoattractant protein-1 (MCP-1), a proinflammatory chemokine related to diabetes and cardiovascular disease. Since obesity is triggered by energy dense diets, we hypothesised that...
19.
Bumke-Vogt C, Osterhoff M, Borchert A, Guzman-Perez V, Sarem Z, Birkenfeld A, et al.
PLoS One
. 2014 Aug;
9(8):e104321.
PMID: 25136826
The flavones apigenin (4',5,7,-trihydroxyflavone) and luteolin (3',4',5,7,-tetrahydroxyflavone) are plant secondary metabolites with antioxidant, antiinflammatory, and anticancer activities. We evaluated their impact on cell signaling pathways related to insulin-resistance and type...
20.
Wagner R, Thorand B, Osterhoff M, Muller G, Bohm A, Meisinger C, et al.
Diabetologia
. 2013 Aug;
56(10):2176-80.
PMID: 23979484
Aims/hypothesis: Prediabetes is a collective term for different subphenotypes (impaired glucose tolerance [IGT] and/or impaired fasting glucose [IFG]) with different pathophysiologies. A positive family history for type 2 diabetes (FHD)...